PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.54%
Positive revenue growth while AVGO is negative. John Neff might see a notable competitive edge here.
13.64%
Positive gross profit growth while AVGO is negative. John Neff would see a clear operational edge over the competitor.
-13.86%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-13.86%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-21.22%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-18.31%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-22.54%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
1.95%
Slight or no buybacks while AVGO is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
1.97%
Slight or no buyback while AVGO is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
-60.38%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-65.89%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
179.08%
10Y revenue/share CAGR above 1.5x AVGO's 33.63%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
23.81%
5Y revenue/share CAGR at 50-75% of AVGO's 33.63%. Martin Whitman would worry about a lagging mid-term growth trajectory.
-22.08%
Negative 3Y CAGR while AVGO stands at 33.63%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
237.34%
10Y OCF/share CAGR under 50% of AVGO's 3135.31%. Michael Burry would worry about a persistent underperformance in cash creation.
199.82%
Below 50% of AVGO's 3135.31%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
10.76%
3Y OCF/share CAGR under 50% of AVGO's 3135.31%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
265.36%
Below 50% of AVGO's 1719.73%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
30.85%
Below 50% of AVGO's 1719.73%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-28.55%
Negative 3Y CAGR while AVGO is 1719.73%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
420.13%
Equity/share CAGR of 420.13% while AVGO is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
88.06%
Equity/share CAGR of 88.06% while AVGO is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
17.68%
Equity/share CAGR of 17.68% while AVGO is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.60%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
10.26%
We show growth while AVGO is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
5.37%
Positive asset growth while AVGO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
6.30%
BV/share growth above 1.5x AVGO's 1.69%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-1.85%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
7.40%
We increase R&D while AVGO cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-32.34%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.